GRISACTIN ULTRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Grisactin Ultra, and what generic alternatives are available?
Grisactin Ultra is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in GRISACTIN ULTRA is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRISACTIN ULTRA?
- What are the global sales for GRISACTIN ULTRA?
- What is Average Wholesale Price for GRISACTIN ULTRA?
Summary for GRISACTIN ULTRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 5,322 |
| DailyMed Link: | GRISACTIN ULTRA at DailyMed |
US Patents and Regulatory Information for GRISACTIN ULTRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062438-002 | Nov 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062438-001 | Nov 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062178-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
